<div><div></div><div>On December 17, 2025, Evoke Pharma Inc announced significant management and board changes following the consummation of a merger. Several directors and officers, including the CEO, CFO, and CMO, ceased their roles.<div><table><tbody><tr><td>Individual</td><td>Cam L. Garner</td><td>Matthew J. D’Onofrio</td><td>Todd C. Brady, M.D., Ph.D.</td><td>Malcolm R. Hill, Pharm.D.</td><td>Greg Pyszczymuka</td><td>Vickie W. Reed</td><td>Benjamin Smeal</td><td>Kenneth J. Widder, M.D.</td><td>Mark Kowieski</td><td>Marilyn R. Carlson, D.M.D., M.D.</td></tr><tr><td>Role</td><td>Director</td><td>CEO</td><td>Director</td><td>Director</td><td>Director</td><td>Director</td><td>Director</td><td>Director</td><td>CFO</td><td>CMO</td></tr><tr><td>Type of Change</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td><td>Ceased</td></tr><tr><td>Effective Date</td><td>Dec 17, 2025</td><td>Dec 18, 2025</td><td>Dec 17, 2025</td><td>Dec 17, 2025</td><td>Dec 17, 2025</td><td>Dec 17, 2025</td><td>Dec 17, 2025</td><td>Dec 17, 2025</td><td>Dec 18, 2025</td><td>Dec 18, 2025</td></tr><tr><td>Reason</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td><td>Merger</td></tr><tr><td>Replacement Info</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr><tr><td>Background Details</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>Board/Committee Role Changes</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr></tbody></table></div>Original SEC Filing: Evoke Pharma Inc [ EVOK ] - 8-K - Dec. 17, 2025<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

EVOK

Evoke Pharma Inc announced major management and board changes after a merger on December 17, 2025. Key executives, including the CEO, CFO, and CMO, ceased their roles. The changes were effective immediately, but replacement details were not disclosed. This information is based on the company's SEC filing.

Evoke Pharma Announces Management and Board Changes Following Merger